Movement Alert|Verisk Analytics Falls 5.03% in Regular Trading, Barclays Slashes Target Price Amid Ongoing Legal Uncertainty

Market Focus
Yesterday

On September 9, Verisk Analytics fell 5.03% in regular trading, trading at $176.44 per share, with turnover of approximately $65.96 million. The decline was driven by a sharp target price cut from Barclays and continued legal overhang from the AccuLynx acquisition dispute.

On September 8, Barclays reduced its price target on Verisk Analytics from $275 to $225, an 18% cut, while maintaining its Overweight rating. The significant downward revision weighed on market sentiment. According to FactSet, the analyst consensus mean target now stands at $237.29.

Adding to the pressure, the company faces unresolved legal risk stemming from its terminated $2.35 billion acquisition of roofing software firm AccuLynx. A Delaware Chancery Court ruled that Verisk's termination of the merger agreement was invalid, ordering the company to continue performing under the deal, including seeking regulatory clearance. On August 18, Verisk filed an appeal with the Delaware Supreme Court, but the legal uncertainty continues to weigh on the stock's valuation.

Verisk Analytics reported solid Q2 results on July 29, with adjusted EPS of $1.98 beating the $1.93 estimate, and revenue of $806.3 million exceeding the $804 million consensus. Full-year guidance was maintained unchanged.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10